Login / Signup

Evaluation of Pharmacist Impact on Patients Initiating Eculizumab for Atypical Hemolytic Uremic Syndrome in the Inpatient Setting.

Paul Christopher ParishDonald C MooreMegan WaymanJustin R Arnall
Published in: The Annals of pharmacotherapy (2022)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • palliative care
  • prognostic factors
  • mental health
  • case report
  • patient reported outcomes